Propranolol Hydrochloride 10 MG Oral Tablet
INDICATIONS AND USAGE Hypertension Propranolol Hydrochloride Tablets USP are indicated in the management of hypertension. They may be used alone or used in combination with other antihypertensive agents, particularly a thiazide diuretic. Propranolol Hydrochloride Tablets USP are not indicated in the management of hypertensive emergencies. Angina Pectoris Due to Coronary Atherosclerosis Propranolol Hydrochloride Tablets USP are indicated to decrease angina frequency and increase exercise tolerance in patients with angina pectoris. Atrial Fibrillation Propranolol Hydrochloride Tablets USP are indicated to control ventricular rate in patients with atrial fibrillation and a rapid ventricular response. Myocardial Infarction Propranolol Hydrochloride Tablets USP are indicated to reduce cardiovascular mortality in patients who have survived the acute phase of Myocardial Infarction and are clinically stable. Migraine Propranolol Hydrochloride Tablets USP are indicated for the prophylaxis of common migraine headache. The efficacy of propranolol in the treatment of a migraine attack that has started has not been established, and propranolol is not indicated for such use. Essential Tremor Propranolol Hydrochloride Tablets USP are indicated in the management of familial or hereditary essential tremor. Familial or essential tremor consists of involuntary, rhythmic, oscillatory movements, usually limited to the upper limbs. It is absent at rest, but occurs when the limb is held in a fixed posture or position against gravity and during active movement. Propranolol hydrochloride causes a reduction in the tremor amplitude, but not in the tremor frequency. Propranolol Hydrochloride Tablets USP are not indicated for the treatment of tremor associated with Parkinsonism. Hypertrophic Subaortic Stenosis Propranolol Hydrochloride Tablets USP improves NYHA functional class in symptomatic patients with Hypertrophic Subaortic Stenosis. Pheochromocytoma Propranolol Hydrochloride Tablets USP are indicated as an adjunct to alpha-adrenergic blockade to control blood pressure and reduce symptoms of catecholamine-secreting tumors.
Teva Pharmaceuticals USA, Inc.
ROUND ORANGE PLIVA 467
PLIVA 467 ROUND ORANGE
Related Pills
propranolol hydrochloride tablet
teva pharmaceuticals usa, inc.
Propranolol Hydrochloride 10 MG Oral Tablet
Pliva Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED Propranolol Hydrochloride Tablets USP 10 mg – orange, round, convex, debossed tablets on one side with PLIVA 467 and scored on the other side. Available in bottles of 100 (NDC: 50111- 467 -01) and 1000 (NDC: 50111- 467 -03). 20 mg – blue, round, convex, debossed tablets on one side with PLIVA 468 and scored on the other side. Available in bottles of 100 (NDC: 50111- 468 -01) and 1000 (NDC: 50111- 468 -03). 40 mg – green, round, convex, debossed tablets on one side with PLIVA 469 and scored on the other side. Available in bottles of 100 (NDC: 50111- 469 -01) and 1000 (NDC: 50111- 469 -03). 60 mg – pink, round, convex, debossed tablets on one side with PLIVA 470 and scored on the other side. Available in bottles of 100 (NDC: 50111- 470 -01). 80 mg – yellow, round, convex, debossed tablets on one side with PLIVA 471 and scored on the other side. Available in bottles of 100 (NDC: 50111- 471 -01) and 500 (NDC: 50111- 471 -02). Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). PROTECT FROM LIGHT. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Manufactured For: TEVA PHARMACEUTICALS USA, INC. North Wales, PA 19454 Rev. C 1/2015
More pills like ROUND PLIVA 467